Storia in 2 fonti

Traws Pharma Stock Falls As UK Regulator Delays Key Flu Study - Traws Pharma (NASDAQ:TRAW)

Traws Pharma shares fell after UK regulators deferred a planned influenza challenge study for tivoxavir marboxil, delaying clinical development.

Raccontata da

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

benzinga.comStai leggendo1 mese fa

Traws Pharma shares fell after UK regulators deferred a planned influenza challenge study for tivoxavir marboxil, delaying clinical development.

Traws Pharma (TRAW) announced that the planned test of tivoxavir marboxil in a Phase 2a human influenza challenge study has been deferred due to...